These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Harris GC; Aston-Jones G Neuropsychopharmacology; 1993 Dec; 9(4):303-11. PubMed ID: 7905738 [TBL] [Abstract][Full Text] [Related]
31. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal]. Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100 [TBL] [Abstract][Full Text] [Related]
32. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. Preston KL; Bigelow GE; Liebson IA J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074 [TBL] [Abstract][Full Text] [Related]
33. Adenosine triphosphate blocks opiate withdrawal symptoms in rats and mice. Gomaa AA; Moustafa SA; Farghali AA Pharmacol Toxicol; 1989 Jan; 64(1):111-5. PubMed ID: 2755901 [TBL] [Abstract][Full Text] [Related]
35. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651 [TBL] [Abstract][Full Text] [Related]
36. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice. Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539 [TBL] [Abstract][Full Text] [Related]
37. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies. Windh RT; Little PJ; Kuhn CM J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109 [TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK; Bhateja P; Singh TG; Singh N Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544 [TBL] [Abstract][Full Text] [Related]
39. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle. Harris AC; Atkinson DM; Aase DM; Gewirtz JC Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512 [TBL] [Abstract][Full Text] [Related]
40. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users. Lubman D; Koutsogiannis Z; Kronborg I Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]